Guided Therapeutics, Inc. (OTCMKTS:GTHP) Sees Large Increase in Short Interest

Guided Therapeutics, Inc. (OTCMKTS:GTHP) was the recipient of a significant increase in short interest in the month of February. As of February 15th, there was short interest totalling 13,800 shares, an increase of 40.8% from the January 31st total of 9,800 shares. Based on an average daily volume of 28,200 shares, the short-interest ratio is presently 0.5 days.

Guided Therapeutics Price Performance

OTCMKTS GTHP traded down $0.01 on Wednesday, hitting $0.10. 28,256 shares of the company’s stock were exchanged, compared to its average volume of 17,319. The firm’s 50-day moving average price is $0.13 and its two-hundred day moving average price is $0.15. The firm has a market cap of $6.25 million, a price-to-earnings ratio of -3.19 and a beta of 0.61. Guided Therapeutics has a fifty-two week low of $0.06 and a fifty-two week high of $0.23.

About Guided Therapeutics

Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.